AG0034YM

1953-04-4 | (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide

AG0034YM

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	1953-04-4
Catalog Number	AG0034YM(AGN-PC-0QNKUX)
Chemical Name	(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide
EC Number	217-780-5
IUPAC Name	(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide
InChI	InChI=1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1
InChI Key	QORVDGQLPPAFRS-XPSHAMGMSA-N
MDL Number	MFCD00067672
Molecular Formula	C17H22BrNO3
Molecular Weight	368.2655
SMILES	Br.COC=1C=CC2=C3[C@@]4(CCN(C2)C)[C@@H](OC13)C[C@H](C=C4)O
UNII	MJ4PTD2VVW
Synonyms	Galantamin, Galantamine, Galanthamine, Galanthamine Hydrobromide, Lycoremine, Nivalin, Nivaline, Razadyne, Reminyl, Galanthamine hydrobromide, Galantamine hydrobromide, 1953-04-4, Reminyl, Galanthamine (hydrobromide), Nivalin, Razadyne, Galanthamine HBr, MJ4PTD2VVW, UNII-MJ4PTD2VVW, Nivaline (pharmaceutical), C17H22BrNO3, EINECS 217-780-5, MFCD00067672, Lycoremine hydrobromide, Reminyl (TN), (4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol hydrobromide, (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide, SMR000449267, SR-01000597844, galanthaminhydrobromid(1:1), anti-Alzheimer, SR-05000001783, Reminyl XL, Jilcon hydrobromide, Razadyne (TN), (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol hydrobromide, Prestwick_236, PubChem13654, Galanthamine-hydrobromide, AC1L3T0P, AC1Q23LL, CHEMBL1555, Galanthamine hydrogen bromide, GALANTHAMINEHYDROBROMIDE, MLS000758283, MLS001401401, Galanthamine Hydrobromide,(S), SCHEMBL177993, SPECTRUM1501202, Nivaline (C17 pharmaceutical), (+/-)-Galantamine hydrobromide, DTXSID4052768, Galantamine hydrobromide [USAN], (+/-)-Galanthamine hydrobromide, QORVDGQLPPAFRS-XPSHAMGMSA-N, Galantamine hydrobromide (racemic), HMS1569F18, HMS1921P21, Reminyl, 69353-21-5, Galantamine hydrobromide, (+/-)-, HY-A0009, AC-469, CCG-38829, CG0027, Galantamine hydrobromide (JAN/USAN), Galantamine hydrobromide [USAN:USP], s1339, AKOS007930166, AKOS015960209, CS-0378, MCULE-7403371703, NC00061, 193146-85-9, AK146319, AS-12155, BC200303, CPD000449267, GP-37267, LS-35389, SAM001246978, LS-185021, FT-0082629, G0293, ST24047324, D02173, J10353, W-5061, 953G044, R-113675, SR-01000597844-1, SR-01000597844-5, SR-05000001783-3, Z1558572528, Galanthamine hydrobromide from Lycoris sp., >=94% (TLC), UNII-5N4SA4KQX9 component QORVDGQLPPAFRS-XPSHAMGMSA-N, (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol hydrobromide, 1,2,3,4,6,7,7a,11c-Octahydro-9-methoxy-2-methyl-benzofuro(4,3,2-efg)(2)benzazocin-6-ol HBr, 4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide, 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide (1:1), (4aR,6S,8aR)-rel-, 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide (1:1), (4aS,6R,8aS)-, 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide, (4aalpha,6beta,8ar*)-, 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide, (4aS,6R,8aS)-, 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,hydrobromide, (4aS,6R,8aS)-, Benzofuro(4,3,2-efg)(2)benzazocin-6-ol, 1,2,3,4,6,7,7a,11c-octahydro-9-methoxy-2-methyl-, hydrobromide, galanthamine, Nivaline, Razadyne ER, Jilkon hydrobromide, UNII-5N4SA4KQX9, 5N4SA4KQX9, AR-1J1137, CID121587, ACN-035567, Galanthamine hydrobromide, 98% - 1G 1g, 69353-21-5, 7147-25-3,

Complexity	440
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	3
Defined Bond Stereocenter Count	0
Exact Mass	367.078g/mol
Formal Charge	0
Heavy Atom Count	22
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	368.271g/mol
Monoisotopic Mass	367.078g/mol
Rotatable Bond Count	1
Topological Polar Surface Area	41.9A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H300
Packing Group	Ⅲ
Precautionary statements	P264-P270-P301+P310a-P321-P405-P501a
UN Code	UN 1544

Certificate of Analysis

Lot Number